rs267607165
Positions:
Variant summary
Our verdict is Pathogenic. Variant got 15 ACMG points: 15P and 0B. PM2PP2PP3_StrongPP5_Very_Strong
The NM_006086.4(TUBB3):c.1228G>A(p.Glu410Lys) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Genomes: not found (cov: 33)
Consequence
TUBB3
NM_006086.4 missense
NM_006086.4 missense
Scores
9
9
1
Clinical Significance
Conservation
PhyloP100: 9.92
Genes affected
TUBB3 (HGNC:20772): (tubulin beta 3 class III) This gene encodes a class III member of the beta tubulin protein family. Beta tubulins are one of two core protein families (alpha and beta tubulins) that heterodimerize and assemble to form microtubules. This protein is primarily expressed in neurons and may be involved in neurogenesis and axon guidance and maintenance. Mutations in this gene are the cause of congenital fibrosis of the extraocular muscles type 3. Alternate splicing results in multiple transcript variants. A pseudogene of this gene is found on chromosome 6. [provided by RefSeq, Oct 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 15 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PP2
Missense variant in gene, where missense usually causes diseases (based on misZ statistic), TUBB3. . Gene score misZ 4.5786 (greater than the threshold 3.09). Trascript score misZ 5.665 (greater than threshold 3.09). GenCC has associacion of gene with tubulinopathy-associated dysgyria, complex cortical dysplasia with other brain malformations 1, congenital fibrosis of extraocular muscles, fibrosis of extraocular muscles, congenital, 3A, with or without extraocular involvement.
PP3
MetaRNN computational evidence supports a deleterious effect, 0.94
PP5
Variant 16-89935679-G-A is Pathogenic according to our data. Variant chr16-89935679-G-A is described in ClinVar as [Pathogenic]. Clinvar id is 6967.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-89935679-G-A is described in Lovd as [Pathogenic].
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TUBB3 | NM_006086.4 | c.1228G>A | p.Glu410Lys | missense_variant | 4/4 | ENST00000315491.12 | NP_006077.2 | |
TUBB3 | NM_001197181.2 | c.1012G>A | p.Glu338Lys | missense_variant | 4/4 | NP_001184110.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TUBB3 | ENST00000315491.12 | c.1228G>A | p.Glu410Lys | missense_variant | 4/4 | 1 | NM_006086.4 | ENSP00000320295 | P1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 genomes
Cov.:
33
GnomAD4 exome Cov.: 31
GnomAD4 exome
Cov.:
31
GnomAD4 genome Cov.: 33
GnomAD4 genome
Cov.:
33
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:7Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Fibrosis of extraocular muscles, congenital, 3A, with or without extraocular involvement Pathogenic:2Other:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Jan 08, 2010 | - - |
Pathogenic, no assertion criteria provided | research | CHU Sainte-Justine Research Center, University of Montreal | Aug 12, 2016 | More than 6 individuals described with this mutation, and in vitro functional studies - |
not provided, no classification provided | literature only | GeneReviews | - | - - |
Complex cortical dysplasia with other brain malformations 1 Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | Jun 04, 2015 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Centre for Mendelian Genomics, University Medical Centre Ljubljana | Jan 01, 2016 | This variant was classified as: Pathogenic. The following ACMG criteria were applied in classifying this variant: PS1,PS3,PM2. - |
TUBB3-Releated Disorders Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Rady Children's Institute for Genomic Medicine, Rady Children's Hospital San Diego | Jun 19, 2019 | This variant has been previously reported as a de novo heterozygous change in patients with hypoplasia of oculomotor nerves, hypoplasia of the corpus callosum, developmental delay, facial weakness, and cyclic vomiting (PMID: 20074521, 23378218, 25559402, 29289389). Functional studies have shown that the c.1228G>A (p.Glu410Lys) variant inhibits axonal transport of vesicles and mitochondria (PMID: 23503589). This variant is in the H12 helix of beta-tubulin and changes the negative charge on the surface of the microtubule, which is important for binding to kinesin superfamily motor proteins (KIFs). The disrupted binding of axonal transport KIFs to microtubules alters the localization of KIFs in neurons and inhibits axon elongation (PMID: 23503589). It is absent from the ExAC and gnomAD population databases and thus is presumed to be rare. The c.1228G>A (p.Glu410Lys) variant affects a highly conserved amino acid and is predicted by multiple in silico tools to have a deleterious effect on protein function. Analysis of the parental samples showed the mother is negative and the father is negative for this variant, indicating this likely occurred as a de novo event. Based on the available evidence, the c.1228G>A (p.Glu410Lys) variant is classified as Pathogenic. - |
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Sep 06, 2022 | Published functional studies demonstrate E410K affected microtubule polymerization and depolymerization rates as well as kinesin interactions on microtubules and reduced axonal transport of mitochondria in peripheral neurons independent of tubulin isoform (Tischfield et al., 2010; Niwa et al., 2013); Missense variants in this gene are often considered pathogenic (HGMD); Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 29289389, 30272120, 23378218, 25559402, 28299356, 30440138, 29382549, 28677066, 31226147, 20074521, 32573066, 20301522, 20829227, 32005694, 23503589) - |
TUBB3-related disorder Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | May 10, 2023 | The TUBB3 c.1228G>A variant is predicted to result in the amino acid substitution p.Glu410Lys. This variant has been reported to occur de novo in multiple individuals affected by what is known as 'TUBB3 E410K syndrome' (Chew et al. 2013. PubMed ID: 23378218; Romaniello et al. 2017. PubMed ID: 28677066; Tischfield et al. 2010. PubMed ID: 20074521; Grant et al. 2018. PubMed ID: 30272120). Patients were reported to have congenital fibrosis of the extraocular muscles, facial weakness, developmental delay, and possible peripheral neuropathy; however, early signs of this disorder may include fetal distress, stridor, and/or tracheomalacia (Chew et al. 2013. PubMed ID: 23378218). In vitro functional studies indicate that the p.Glu410Lys change significantly inhibits axonal transport of vesicles and mitochondria (Niwa et al. 2013. PubMed ID: 23503589). This variant has not been reported in a large population database (http://gnomad.broadinstitute.org), indicating this variant is rare. Given the evidence, we interpret c.1228G>A (p.Glu410Lys) as pathogenic. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Uncertain
.;.;D
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Pathogenic
D
LIST_S2
Uncertain
D;D;D
M_CAP
Pathogenic
D
MetaRNN
Pathogenic
D;D;D
MetaSVM
Uncertain
D
MutationAssessor
Pathogenic
.;.;M
MutationTaster
Benign
D;D;D;D
PrimateAI
Pathogenic
D
PROVEAN
Uncertain
N;N;N
REVEL
Pathogenic
Sift
Uncertain
D;.;.
Sift4G
Uncertain
D;D;D
Polyphen
0.91
.;.;P
Vest4
MutPred
0.80
.;.;Gain of ubiquitination at E410 (P = 0.009);
MVP
MPC
1.7
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at